header logo image

Diabetes Patients And Tech Companies See Value In Continuous Glucose Monitoring – KJZZ

May 17th, 2017 12:50 am

KJZZ
Diabetes Patients And Tech Companies See Value In Continuous Glucose Monitoring
KJZZ
Yehuda Friedman is a hockey fanatic. When the 11-year-old isn't on the ice, he's zooming around his house in Phoenix on rollerblades, taking shots on the net in the living room. But two years ago Yehuda started feeling lethargic and lost a bunch of weight.

Excerpt from:
Diabetes Patients And Tech Companies See Value In Continuous Glucose Monitoring - KJZZ

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick